Skip to main content
Premium Trial:

Request an Annual Quote

BioSystems International Installs Spotfire s DecisionSite Software

NEW YORK, Dec. 13 (GenomeWeb News) - BioSystems International has purchased Spotfire's flagship DecisionSite software, the company said today. 


BSI has deployed DecisionSite to investigate and analyze several classes of biomarkers, including stratification markers that predict the likelihood of a drug response; efficacy biomarkers that predict a clinical outcome; screening markers for the early detection of diseases; and prognostic markers to predict the likely course of the disease, Spotfire said.


Financial terms of the deal were not disclosed.

The Scan

Omicron's Emergence

The World Health Organization has called Omicron a SARS-CoV-2 "variant of concern," the Los Angeles Times writes.

Not as Much

Merck's pill to treat COVID-19 reduces the risk of hospitalization and death among COVID-19 patients by less than previously reported, the New York Times says.

Bats That Hang Together

Discover magazine writes that researchers have found a social microbiome among vampire bats.

PLOS Papers on CEWAS, Simian Varicella Virus Transcriptome, Dermatomyositis Markers

In PLOS this week: multi-omic approach to home in on genetic risk variants, transcriptomic analysis of the simian varicella virus, and more.